CPNE1 promotes non-small cell lung cancer progression by interacting with RACK1 via the MET signaling pathway

[31] Tomsig JL(2003)Identification of targets for calcium signaling through the copine family of proteins. Characterization of a coiled-coil copine-binding motif J Biol Chem 278 10048-358

[32] Creutz CE(2020)MiR-195-5p is a potential factor responsible for CPNE1 differential expression between subtypes of non-small cell lung cancer J Cancer 11 2610-103

[33] Park N(2012)Rack1 promotes epithelial cell-cell adhesion by regulating E-cadherin endocytosis Oncogene 31 376-859

[34] Yoo JC(2012)EphB3 suppresses non-small-cell lung cancer metastasis via a PP2A/RACK1/Akt signalling complex Nat Commun 3 667-82

[35] Lee YS(2021)PHB2 promotes tumorigenesis via RACK1 in non-small cell lung cancer Theranostics 11 3150-304

[36] Choi HY(2002)Molecular dynamics characterization of the C2 domain of protein kinase Cbeta J Biol Chem 277 12988-616

[37] Hong SG(2007)Insight into intra- and inter-molecular interactions of PKC: design of specific modulators of kinase function Pharmacol Res 55 467-undefined

[38] Hwang EM(2018)Known and novel roles of the MET oncogene in cancer: a coherent approach to targeted therapy Nat Rev Cancer 18 341-undefined

[39] Whittaker CA(2018)Crizotinib in patients with anaplastic lymphoma kinase-positive advanced non-small cell lung cancer versus chemotherapy as a first-line treatment BMC Cancer 18 10-undefined

[40] Hynes RO(2012)Targeting MET in cancer: rationale and progress Nat Rev Cancer 12 89-undefined

[31] Tomsig JL(2003)Identification of targets for calcium signaling through the copine family of proteins. Characterization of a coiled-coil copine-binding motif J Biol Chem 278 10048-358

[32] Creutz CE(2020)MiR-195-5p is a potential factor responsible for CPNE1 differential expression between subtypes of non-small cell lung cancer J Cancer 11 2610-103

[33] Park N(2012)Rack1 promotes epithelial cell-cell adhesion by regulating E-cadherin endocytosis Oncogene 31 376-859

[34] Yoo JC(2012)EphB3 suppresses non-small-cell lung cancer metastasis via a PP2A/RACK1/Akt signalling complex Nat Commun 3 667-82

[35] Lee YS(2021)PHB2 promotes tumorigenesis via RACK1 in non-small cell lung cancer Theranostics 11 3150-304

[36] Choi HY(2002)Molecular dynamics characterization of the C2 domain of protein kinase Cbeta J Biol Chem 277 12988-616

[37] Hong SG(2007)Insight into intra- and inter-molecular interactions of PKC: design of specific modulators of kinase function Pharmacol Res 55 467-undefined

[38] Hwang EM(2018)Known and novel roles of the MET oncogene in cancer: a coherent approach to targeted therapy Nat Rev Cancer 18 341-undefined

[39] Whittaker CA(2018)Crizotinib in patients with anaplastic lymphoma kinase-positive advanced non-small cell lung cancer versus chemotherapy as a first-line treatment BMC Cancer 18 10-undefined

[40] Hynes RO(2012)Targeting MET in cancer: rationale and progress Nat Rev Cancer 12 89-undefined